GlassScriptPhysician profile
Roshan Karki
NPI 1104057165
$15,904.90
in general payments reported to CMS, 2019-2025
25 companies · $1,307 in 2025
The $1,307 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,664 · 2020: $10K · 2021: $387 · 2022: $79.48 · 2023: $317 · 2024: $1,150 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,539 · Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,539.44 |
| Food and Beverage | $1,234.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,102.01 | 2019-2020 | |
| Boston Scientific Corporation | $2,346.05 | 2019-2023 | S-Icd System Magnet |
| Medtronic, INC. | $2,150.89 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $301.23 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Abbott Laboratories | $276.36 | 2019-2025 | Perclose Prostyle |
| Kiniksa Pharmaceuticals International, Plc | $124.99 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $106.56 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $65.53 | 2022-2024 | Camzyos, Eliquis |
| Pfizer INC. | $48.67 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $41.49 | 2023 | |
| Amgen INC. | $40.35 | 2023-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.83 | 2019 | |
| Irhythm Technologies, INC. | $32.18 | 2024 | Zio Monitor, Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $27.51 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.00 | 2025 | Jardiance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catheter Precision INC. | $21.83 | 2025 | |
| Biotronik INC. | $21.63 | 2021 | |
| Inspire Medical Systems, INC. | $18.88 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $18.82 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $17.87 | 2022 | |
| Scpharmaceuticals INC. | $17.38 | 2025 | |
| Novo Nordisk INC | $16.63 | 2023 | Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $16.42 | 2022 | |
| Lantheus Medical Imaging, INC. | $14.73 | 2019 | |
| Bridgebio Pharma, INC. | $14.06 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshan Karki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.